Skip to main content

Roundup Lawsuit: Former CEO To Testify At St. Louis Trial

Roundup Lawsuit: Former CEO To Testify At St. Louis Trial

Roundup Lawsuit: Former CEO To Testify At St. Louis Trial

Introduction

The former CEO of Monsanto has been subpoenaed to testify at a  St. Louis Roundup trial.

This will be the first time where the executive is required to testify over the alleged risks associated with a glyphosate-based herbicide. Bayer, along with attorney Ken Feinberg is finding ways, through a mediation process, to resolve more than 43,000 lawsuits. Feinberg was a part of some of the largest mass-tort settlements, including the BP oil spill, Volkswagen emissions scandal, General Motors ignition switch recall, and September 11th Victim Compensation Fund.

If the company does not reach settlements in the next few weeks, they will not only face juries in Missouri state court next month but also have to be ready for a trial that is expected to begin in February 2020, involving a claim brought by a plaintiff who alleged that exposure to Roundup caused her Non-Hodgkin's lymphoma.

Roundup lawsuits are consolidated under federal multidistrict litigation (MDL No. 2741; In Re: Roundup Products Liability Litigation) in the Northern District of California, presided by U.S. District Judge Vince Chhabria.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients

A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…

FDA Adds New Warnings on Long-Term Opioid Risks

Categories: Opioids

Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!